It is a trading public limited company based in Indore, Madhya Pradesh, India, established in 2005.
2005 | Indore, Madhya Pradesh, India | Struck OffIndmed Pharmaceuticals Limited, a struck off public limited company, was established on 18 March 2005 in Indore, Madhya Pradesh, India. Engaging in other wholesale within the trading sector, it holds CIN: U02423MP2005PLC017452. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Sifti Manocha (Additional Director), Neeraj Manocha (Director), Kunal Dang (Additional Director). Past directors included Chandra Prakash Manocha, Rita Manocha. Its latest AGM occurred on 25 September 2018, with the balance sheet filed on 31 March 2018. It is based at Annex 100, Sda Compound, Lasudiya Mori Dewas Naka, Indore, Madhya Pradesh, 452001.
U02423MP2005PLC017452
017452
18 March 2005
₹0.50 M
₹0.50 M
Roc Gwalior
Unlisted
Struck Off
Explore comprehensive insights into Indmed Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sifti Manocha | Additional Director | 11 Jun 2019 | Current |
| Neeraj Manocha | Director | 22 Mar 2005 | Current |
| Kunal Dang | Additional Director | 11 Jun 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Jun 2019 | Past |
| Pramod Abcsdd | Director | 11 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Indmed Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2016, Indmed Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Indmed Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Indmed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indmed Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sifti Manocha was appointed as a Additional Director was appointed as a Additional Director on 11 Jun 2019 & has been associated with this company since 6 years 5 months . was completed.
Progress on Kunal Dang was appointed as a Additional Director was appointed as a Additional Director on 11 Jun 2019 & has been associated with this company since 6 years 5 months . was documented.
Indmed Pharmaceuticals Limited last Annual general meeting of members was held on 25 Sep 2018 as per latest MCA records. was recorded as a recent event.
Progress on Indmed Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Gwalior. was documented.
The activity Neeraj Manocha was appointed as a Director was appointed as a Director on 22 Mar 2005 & has been associated with this company since 20 years 8 months . was completed.
The activity Indmed Pharmaceuticals Limited was registered on 18 Mar 2005 with Roc Gwalior & aged 20 years 8 months as per MCA records. was completed.
The CIN of Indmed Pharmaceuticals Limited is U02423MP2005PLC017452.
Indmed Pharmaceuticals Limited is headquartered at Annex 100, Sda Compound, Lasudiya Mori Dewas Naka, Indore, Madhya Pradesh, 452001.
Indmed Pharmaceuticals Limited was incorporated on 18 March 2005.
The current directors of Indmed Pharmaceuticals Limited are
The primary industry of Indmed Pharmaceuticals Limited is Trading.
Indmed Pharmaceuticals Limited is unlisted.
The authorized capital of Indmed Pharmaceuticals Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Indmed Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX